Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
CAS NO.82640-04-8
1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you;
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries. We can provide good references about our company. As for the quality of the products, we 're sure they can satisfy you well enough;
3. Package: Professional packing with professional materials
4. Delivery: We have products in stock, and we will deliver them soon when your PO arrived.
Meanwhile we will give you the tracking number in order to make you know the exact location of the products. We will keep track of the product until they arrive you; We choose the best courier service for you, and with the delivery around 4-7 working days.
5. Service: Best Service with after-sales service and consultation.
Raloxifene Hydrochloride Use in Cancer
Raloxifene hydrochloride is approved to prevent: Breast cancer.
Raloxifene hydrochloride is used to decrease the chance of invasive breast cancer in postmenopausal women who have a high risk for developing the disease or who have osteoporosis.
Raloxifene hydrochloride is also approved to prevent and treat:Osteoporosis in postmenopausal women.
Raloxifene hydrochloride is also being studied in the treatment of other types of cancer.
Product name | Raloxifene hydrochloride |
Other name | Raloxifene HCL;KEOXIFENE;AKOS 92138 |
Possible similar drug | Evista; Evista |
CAS register number | 82640-04-8 |
Steroid Class | Anti Estrogen Steroids |
Appearance | Light yellow powder |
Molecular formula | C28H28ClNO4S |
Molecular weight | 510.04 |
Melting point | 250-253°C |
Assay | 99% |
Brand | vanz |
Manufacturer | vanz |
Treatment for | the treatment/prevention of osteoporosis and reduction of breast cancer riskinpostmenopausalwomen. |
Storage | Shading, confined preservation |
Certificate of Analysis
ITEMS | SPECIFICATION | RESULT | |
Appearance | White &off-white powder | Conforms | |
Grade | Anti Estrogen Steroids | Conforms | |
Solubility | Soluble in 10% sodium hydroxide solution. Slightly Soluble in methanol. Insoluble in water | Conforms | |
Identifications | Infrared Absorption | Conforms | |
Loss on drying | ≤0.5% | 0.4% | |
Residue on ignition | ≤0.1% | 0.06% | |
Heavy metals | ≤10ppm | Conforms | |
Raloxifene Impurity1 | ≤0.20 % | 0.10% | |
Any unspecified individual impurity 2 | ≤0.10% | Max. 0.08% | |
Total impurities | ≤0.50% | 0.40% | |
Raloxifene HCl | ≥98.0% | 99.0% |